Core Scientific's largest shareholder, Two Seas Capital, has expressed opposition to the $9 billion sale to CoreWeave.
4 hours ago

According to Odaily Planet Daily, Two Seas Capital, Core Scientific's largest active shareholder, has issued an open letter stating that it will vote against the proposed $9 billion sale of Core Scientific to CoreWeave at a shareholder meeting later this year. Two Seas Capital called the valuation "manifestly inadequate" and urged other shareholders to join in opposing the deal. Previous reports indicated that CoreWeave had announced on July 7th its acquisition of Core Scientific in an all-stock transaction valued at $9 billion, representing a 66% premium to Core Scientific's share price when negotiations resumed on June 25th. (prnewswire)

最热快讯
资讯热榜
日榜
周榜
Ethereum's next target after breaking through $4,000 may be $6,400
A whale bought $6.17 million worth of WETH through a revolving loan when ETH broke through $4,000.
In the past hour, ETH short positions were liquidated by $24.17 million
AguilaTrades holds over $5 million in ETH long positions
ETH breaks through 4000 USDT, up 3.78% in 24 hours
Solana Treasury's SPAC IPO plan terminated